Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies
Gill Schierhout, Skye McGregor, Antoine Gessain, et al.
The Lancet Infectious Diseases (2019) Vol. 20, Iss. 1, pp. 133-143
Closed Access | Times Cited: 193

Showing 51-75 of 193 citing articles:

Correction to: Human T-cell leukaemia virus type 1 associated pulmonary disease: clinical and pathological features of an under-recognised complication of HTLV-1 infection
Lloyd Einsiedel, Fabian Chiong, Hubertus Jersmann, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 20
The Epidemiological Impact of STIs among General and Vulnerable Populations of the Amazon Region of Brazil: 30 years of Surveillance
Luiz Fernando Almeida Machado, Ricardo Roberto de Souza Fonseca, Maria Alice Freitas Queiroz, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 855-855
Open Access | Times Cited: 18
Integrative and Multidisciplinary Care for People Living With Human T-Cell Lymphotropic Virus in Bahia, Brazil: 20 Years of Experience
Bernardo Galvão–Castro, Maria Fernanda Rios Grassi, Ana Verena Galvão-Castro, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection
Yuan Zong, Koju Kamoi, Hisako Kurozumi-Karube, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 7
Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies
Niloofar Seighali, Arman Shafiee, Mohammad Ali Rafiee, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)
Carmen de Mendoza, Graham P. Taylor, Antoine Gessain, et al.
NeuroImmune Pharmacology and Therapeutics (2024) Vol. 3, Iss. 1, pp. 61-69
Open Access | Times Cited: 2
Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
Jake S. O’Donnell, Noushin Jaberolansar, Keith J. Chappell
The Lancet Microbe (2024) Vol. 5, Iss. 4, pp. e400-e408
Open Access | Times Cited: 2
Cell Culture Evaluation Hints Widely Available HIV Drugs Are Primed for Success if Repurposed for HTLV-1 Prevention
Mphatso D. Kalemera, Allison K. Maher, Margarita Dominguez‐Villar, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 730-730
Open Access | Times Cited: 2
Current State of Therapeutics for HTLV-1
T. Wang, Ashley Hirons, Marcel Doerflinger, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1616-1616
Open Access | Times Cited: 2
Adult T-cell leukemia/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1
Jill‐Léa Ramassamy, Patricia Tortevoye, Balthazar Ntab, et al.
Blood Advances (2020) Vol. 4, Iss. 9, pp. 2044-2048
Open Access | Times Cited: 18
Aberrant Splicing Events and Epigenetics in Viral Oncogenomics: Current Therapeutic Strategies
Flavia Zita Francies, Zodwa Dlamini
Cells (2021) Vol. 10, Iss. 2, pp. 239-239
Open Access | Times Cited: 17
Autophagy in Viral Development and Progression of Cancer
Alejandra Suares, María Victoria Medina, Omar A. Coso
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 17
Epigenomic regulation of human T-cell leukemia virus by chromatin-insulator CTCF
Xiaogang Cheng, Ancy Joseph, Victor Castro, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 5, pp. e1009577-e1009577
Open Access | Times Cited: 16
Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil
Angélica Espinosa Miranda, Carolina Rosadas, Tatiane Assone, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
Tatiane Assone, Soraya Maria Menezes, Fernanda de Toledo Gonçalves, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 12
HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
Daniel Bradshaw, Graham P. Taylor
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission
Akiko Kowada
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 2, pp. e0011129-e0011129
Open Access | Times Cited: 6
Epidemiological Features and Outcomes of HTLV-1 Carriers Diagnosed With Cancer: A Retrospective Cohort Study in an Endemic Country
Bryan Valcárcel, Daniel Enríquez, Gabriel De la Cruz-Ku, et al.
JCO Global Oncology (2023), Iss. 9
Open Access | Times Cited: 6
Dichotomy in Fatal Outcomes in a Large Cohort of People Living with HTLV-1 in São Paulo, Brazil
Rosa Maria Nascimento Marcusso, Johan Van Weyenbergh, João Victor Luisi de Moura, et al.
Pathogens (2019) Vol. 9, Iss. 1, pp. 25-25
Open Access | Times Cited: 19
Pulmonary Disease Is Associated With Human T-Cell Leukemia Virus Type 1c Infection: A Cross-sectional Survey in Remote Aboriginal Communities
Lloyd Einsiedel, Hai Pham, Mohammad Radwanur Talukder, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1498-e1506
Closed Access | Times Cited: 17
Neglected tropical rheumatic diseases
Rasmi Ranjan Sahoo, Anupam Wakhlu, Vikas Agarwal
Clinical Rheumatology (2022) Vol. 41, Iss. 5, pp. 1293-1304
Closed Access | Times Cited: 9
Prevalence and Risk Factors for HTLV-1/2 Infection in Quilombo Remnant Communities Living in the Brazilian Amazon
Wandrey Roberto dos Santos Brito, Greice de Lemos Cardoso Costa, Lourival Marques Roland, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 9
Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains
Olivier Cassar, Alexandra Desrames, Ambroise Marçais, et al.
Emerging Microbes & Infections (2020) Vol. 9, Iss. 1, pp. 913-923
Open Access | Times Cited: 14
Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Alvaro Schwalb, Valeria Pérez-Muto, Rodrigo Cachay, et al.
Pathogens (2020) Vol. 9, Iss. 6, pp. 450-450
Open Access | Times Cited: 13
Updates on the Epidemiology of the Human T-Cell Leukemia Virus Type 1 Infection in the Countries of the Eastern Mediterranean Regional Office of the World Health Organization with Special Emphasis on the Situation in Iran
Mohammad Reza Hedayati‐Moghaddam, Reza Jafarzadeh Esfehani, Hiba El Hajj, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 664-664
Open Access | Times Cited: 8

Scroll to top